Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Japanese Case of Hereditary Transthyretin Amyloid Cardiomyopathy with an Ile68Leu Variant: A Case Report.

Internal medicine (Tokyo, Japan)·2026
Same author

Hemoglobin Response to a Low-Iron Dose in Infantile Anemia.

Cureus·2026
Same author

Breakthrough Varicella During Chemotherapy in Two Vaccinated Children With Acute Leukemia.

Cureus·2026
Same author

Hypokalemia-Induced Rhabdomyolysis Following Prolonged Diarrhea in a Child With Congenital Heart Disease Receiving Loop Diuretics: A Case Report and Literature Review.

Cureus·2026
Same author

NEFL is associated with inhibition of odontoblastic process in odontohypophosphatasia.

Journal of bone and mineral metabolism·2026
Same author

Active Seizures on Arrival at the Hospital During Ambulance Transfers in Children: A Five-Year Record Review.

Cureus·2026
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Related Experiment Video

Updated: May 25, 2026

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
11:22

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

[Regenerative therapy using allogeneic mesenchymal stem cells].

Hajime Ohgushi1, Nobuyoshi Arima, Takeshi Taketani

  • 1Department of Orthopedics, Ookuma Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 17, 2012
PubMed
Summary
This summary is machine-generated.

Allogeneic mesenchymal stem cells (MSC) show potential for regenerative medicine. Clinical experiences suggest MSC are a promising cell therapy for hypophosphatasia and graft versus host disease (GVHD).

More Related Videos

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats
09:31

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Published on: March 30, 2018

Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue
08:15

Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue

Published on: October 8, 2016

Related Experiment Videos

Last Updated: May 25, 2026

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
11:22

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats
09:31

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Published on: March 30, 2018

Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue
08:15

Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue

Published on: October 8, 2016

Area of Science:

  • Stem cell biology
  • Regenerative medicine
  • Immunology

Background:

  • Mesenchymal stem cells (MSC) possess multipotent progenitor cells, exhibiting immunoprivileged and immunosuppressive properties.
  • Allogeneic MSC therapy is a promising treatment for severe acute graft versus host disease (GVHD).
  • MSC demonstrate osteogenic differentiation potential both in vitro and in vivo.

Purpose of the Study:

  • To summarize clinical experiences using allogeneic MSC for regenerative medicine.
  • To explore the application of allogeneic MSC in treating hypophosphatasia, a genetic disorder.
  • To evaluate the efficacy of MSC-based cell therapy.

Main Methods:

  • Utilized allogeneic mesenchymal stem cells (MSC) in a clinical setting.
  • Conducted a pilot study for graft versus host disease (GVHD) treatments.
  • Observed MSC osteogenic differentiation capabilities in vitro and in vivo.

Main Results:

  • Allogeneic MSC therapy showed promise in treating severe acute graft versus host disease (GVHD).
  • MSC exhibited osteogenic differentiation, indicating regenerative potential.
  • Clinical experiences with allogeneic MSC for hypophosphatasia were summarized.

Conclusions:

  • Allogeneic MSC hold significant potential for regenerative medicine applications.
  • MSC-based cell therapy is a viable approach for genetic disorders like hypophosphatasia.
  • Further clinical investigation of allogeneic MSC is warranted for various conditions.